Yes, ProT GOLD is effective for nutritional support for your ESRD patients on Hemodialysis. Oral protein supplementation assists in addressing the catabolic effects of Hemodialysis.
Rich in nitrogen-donor amino acids critical to address conditions and disease states that deplete protein stores. Low in phosphorus and potassium.
Uniquely powerful formulation with an enhanced and fortified amino acid profile. A complete protein supplement with all essential, non-essential, and conditionally essential amino acids. Nano-Hydrolyzed and rapid absorption.
• Pro-T Gold is enhanced with a number of sulfur-containing and aromatic amino acids for better balance at the cellular level including 3g of Arginine and 500mg Taurine per serving.
• Nutrient-dense - 17.5g total protein per 30mL serving, including 2.5g fortified amino acids, 70 calories/serving.
• Sugar, gluten, lactose, and soy-free. Safe for diabetics, dialysis patients, and patients with allergies (natural flavoring).
• Oral or enteral use.
• Berry Flavor in Unit Dose or bottles.
REFERENCES
National Kidney Foundation - www.kidney.org
Perit Dial Int 27(2): 192-195 2007 © 2007 International Society for Peritoneal Dialysis Clinical DIETARY PROTEIN REQUIREMENTS AND DIALYSATE PROTEIN LOSSES IN CHRONIC PERITONEAL DIALYSIS PATIENTS - Wytske M. Westra 1,4, Joel D. Kopple 1,2,3, Raymond T. Krediet 4, Marilyn Appell 1 and Rajnish Mehrotra 1,2 1 Division of Nephrology & Hypertension, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance; 2 David Geffen School of Medicine at UCLA; 3 UCLA School of Public Health, Los Angeles, California, USA; 4 Division of Nephrology, Department of Medicine, Academic Medical Center, Amsterdam, The Netherlands Correspondence to: R. Mehrotra, Division of Nephrology & Hypertension, Harbor-UCLA Medical Center, 1124 W. Carson Street, Torrance, California 90502 USA.
Kopple, J. D. (2001). The National Kidney Foundation K/DOQI clinical practice guidelines for dietary protein intake for chronic dialysis patients. American Journal of Kidney Diseases, 38(4, Suppl. 1), S68 - S73.
Malnutrition in hemodialysis patients. Hakim RM, Levin N. Division of Nephrology, Vanderbilt University Medical Center, Nashville, TN 37232-2372.
Nutritional aspects in hemodialysis. Laville M, Fouque D. Department of Nephrology, Claude-Bernard University, Edouard-Herriot Hospital, Lyon, France. maurice.leville@chu-lyon.fr
Intradialytic parenteral nutrition improves protein & energy homeostasis in chronic hemodialysis patients. Pupim LB, Flakoll PJ, Brouillette JR, Levenhagen DK, Hakim RM, Ikizler TA. Department of Medicine, Division of Nephrology, Department of Surgery, and Department of Biochemistry, Vanderbilt University Medical Center, Nashville, Tennessee 37232-2372, USA.
Therapeutic effects of oral nutritional supplementation during hemodialysis. Caglar K, Fedje L, Dimmitt R, Hakim RM, Shyr Y, Ikizler TA. Department of Medicine, Division of Nephrology, Vanderbilt University Medical Center, 1161 21st Avenue South & Garland, Nashville, TN 37232-2372, USA.
Hemodialysis stimulates muscle and whole body protein loss and alters substrate oxidation. Ikizler TA, Pupim LB, Brouillette JR, Levenhagen DK, Farmer K, Hakim RM, Flakoll PJ. Division of Nephrology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA. alp.ikizler@mcmail.vanderbilt.edu
Protein turnover and amino acid transport kinetics in end-stage renal disease. Raj DS, Zager P, Shah VO, Dominic EA, Adeniyi O, Blandon P, Wolfe R, Ferrando A. Division of Nephrology, University of New Mexico Health Sciences Center, 5th Floor, ACC, 2211 Lomas Boulevard NE, Albuquerque, NM 87131-5271, USA. draj@salud.unm.edu
Randomized double-blind trial of oral essential amino acids for dialysis-associated hypoalbuminemia. Eustace JA, Coresh J, Kutchey C, Te PL, Gimenez LF, Scheel PJ, Walser M. Division of Nephrology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.